Neuronext Clinical Trials (U01 Clinical Trial Optional) Tender, USA - 52847004

Procurement Summary

Country : USA

Summary : Neuronext Clinical Trials (U01 Clinical Trial Optional)

Deadline : 05 Mar 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 52847004

Document Ref. No. : PAR-21-223

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : NATIONAL INSTITUTES OF HEALTH
NIH OER Webmastergrantsinfo@nih.gov
USA
Email :grantsinfo@nih.gov

Tender Details

Tender are invited for NeuroNEXT Clinical Trials (U01 Clinical Trial Optional)

CFDA Number : 93.853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders

Cost Sharing or Matching Requirement : No

Closing Date for Applications: Mar 05, 2024

Posted Date : May 05, 2021

Description: This FOA encourages applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing a future trial, for biomarker validation studies, or for proof of mechanism clinical studies. Diseases chosen for study should be based on the NINDS' strategic plan and clinical research interests (www.ninds.nih.gov/funding/areas/index.htm). Successful applicants will be given access to the NeuroNEXT infrastructure. Following peer review, NINDS will prioritize and order trials that are given access to the NeuroNEXT infrastructure. The NeuroNEXT Clinical Coordinating Center (CCC) will work with the successful applicant to efficiently implement the proposed study. The NeuroNEXT Data Coordinating Center (DCC) will provide statistical and data management support. The NeuroNEXT clinical sites will provide recruitment/retention support as well as on-site implementation of the clinical protocol. Applicants do not need to be part of the existing NeuroNEXT infrastructure.

Documents

 Tender Notice